Royalty Pharma plc
US ˙ NasdaqGS ˙ GB00BMVP7Y09

SecurityRPRX / Royalty Pharma plc
InstitutionTIFF INVESTMENT PROGRAM - TIFF Multi-Asset Fund
Latest Disclosed Ownership21,926 shares
Latest Disclosed Value $ 789,993
TIFF INVESTMENT PROGRAM - TIFF Multi-Asset Fund reports 142.57% increase in ownership of RPRX / Royalty Pharma plc

On August 27, 2025 - TIFF INVESTMENT PROGRAM - TIFF Multi-Asset Fund filed a NPORT-P form disclosing ownership of 21,926 shares of Royalty Pharma plc (US:RPRX) valued at $789,994 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 29, 2025 disclosing 9,039 shares of Royalty Pharma plc. This represents a change in shares of 142.57% during the quarter. The current value of the position is $1,225,006 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP Royalty Pharma EC GB00BMVP7Y09 21,926 12,887 142.57 790 180.78 0.0562
2025-05-29 2025-03-31 NP Royalty Pharma EC GB00BMVP7Y09 9,039 -3,044 -25.19 281 -8.77 0.0220
2025-02-28 2024-12-31 NP Royalty Pharma EC GB00BMVP7Y09 12,083 -4,923 -28.95 308 -35.97 0.0235
2024-11-29 2024-09-30 NP Royalty Pharma EC GB00BMVP7Y09 17,006 17,006 481 0.0366
2022-11-28 2022-09-30 NP Royalty Pharma EC GB00BMVP7Y09 0 349 -100.00 0 -100.00
2022-08-23 2022-06-30 NP Royalty Pharma EC GB00BMVP7Y09 -349 1,877 -84.32 -15 -83.72 -0.0011
2022-05-27 2022-03-31 NP Royalty Pharma EC GB00BMVP7Y09 -2,226 0 -0.00 -87 -2.27 -0.0061
2022-02-23 2021-12-31 NP Royalty Pharma EC GB00BMVP7Y09 -2,226 0 -0.00 -89 10.00 -0.0056
2021-11-23 2021-09-30 NP Royalty Pharma EC GB00BMVP7Y09 -2,226 -2,226 -80 -0.0049
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.